ExpreS2ion Biotech Holding AB
Clinical-stage biotech developing vaccines and immunotherapies via a proprietary protein platform.
EXPRS2 | ST
Overview
Corporate Details
- ISIN(s):
- SE0008348262 (+4 more)
- LEI:
- 549300FJK50P1ORYJC45
- Country:
- Sweden
- Address:
- C/O Mindpark, 252 25 Helsingborg
- Website:
- https://www.expres2ionbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
ExpreS2ion Biotech Holding AB is a clinical-stage biotechnology company focused on developing novel vaccines and immunotherapy products. The company leverages its proprietary ExpreS2™ technology platform, which enables the fast and efficient development and production of complex proteins required for new vaccines and biopharmaceuticals. ExpreS2ion's mission is to address critical unmet medical needs and improve global quality of life by creating innovative, lifesaving vaccines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ExpreS2ion Biotech Holding AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ExpreS2ion Biotech Holding AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
